Zero Carbon Capital has invested in Level Nine, a German company revolutionizing bioprocessing through nanozyme technology, targeting sustainable alternatives to petrochemicals.

Target Information: Level Nine

Level Nine is an innovative German firm specializing in the development of groundbreaking nanozyme technology aimed at transforming the bioprocessing industry. This strategic investment marks our inaugural foray into continental Europe, underscoring our commitment to advancing sustainable technologies that offer low-emission alternatives to traditional petrochemicals.

At the forefront of biochemistry, Level Nine is redefining the landscape with its pioneering efforts in nanozyme production. These advanced nanomaterials are engineered to replicate enzyme functions with heightened stability and cost-effectiveness, making them particularly suited for industrial applications.

Industry Overview: Bioprocessing in Germany

The bioprocessing industry in Germany is rapidly evolving, fueled by a growing demand for sustainable and efficient production methods. As global concerns about climate change intensify, industries are under increasing p